These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4057042)

  • 21. Disposition of metabolically labeled recombinant soluble CD4 (sT4) in male Sprague-Dawley rats following intravenous and subcutaneous administration.
    Davis CB; Boyle KE; Urbanski JJ; Paradysz RT; Fong KL
    Drug Metab Dispos; 1992; 20(5):695-705. PubMed ID: 1358574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
    Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
    Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
    Brunner F; Kolmayr U; Kukovetz WR
    Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of dibucaine. II. Disposition and metabolism of dibucaine in rats.
    Igarashi K; Kasuya F; Fukui M
    J Pharmacobiodyn; 1989 Sep; 12(9):523-9. PubMed ID: 2614642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic properties of the antimuscarinic drug [3H]-hexahydro-sila-difenidol in the rat.
    Rettenmayr NM; Rodrigues de Miranda JF; Rijntjes NV; Russel FG; van Ginneken CA; Strohmann C; Tacke R; Lambrecht G; Mutschler E
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):146-52. PubMed ID: 2234099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue distribution and metabolic disposition of zidovudine in rats.
    de Miranda P; Burnette TC; Good SS
    Drug Metab Dispos; 1990; 18(3):315-20. PubMed ID: 1974192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of high-activity heparin by DEAE-Sephadex and protamine-Sepharose chromatography.
    Piepkorn MW; Schmer G; Lagunoff D
    Thromb Res; 1978 Dec; 13(6):1077-87. PubMed ID: 571151
    [No Abstract]   [Full Text] [Related]  

  • 34. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion.
    Huber M; Guhlmann A; Jansen PL; Keppler D
    Hepatology; 1987; 7(2):224-8. PubMed ID: 3030916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics and tissue distribution of gomphoside in Wistar rats.
    Mutlib AE; Watson TR
    Eur J Drug Metab Pharmacokinet; 1989; 14(2):117-25. PubMed ID: 2591416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The disposition and pharmacokinetics of ketoconazole in the rat.
    Remmel RP; Amoh K; Abdel-Monem MM
    Drug Metab Dispos; 1987; 15(6):735-9. PubMed ID: 2893696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)- 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1- methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs.
    Ito Y; Fukushima T; Sugawara Y; Takaiti O; Nakamura S
    J Pharmacobiodyn; 1991 Sep; 14(9):533-46. PubMed ID: 1779408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs.
    Biehl ML; Prelusky DB; Koritz GD; Hartin KE; Buck WB; Trenholm HL
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):152-9. PubMed ID: 8337696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue distribution, disposition, and metabolism of cyclosporine in rats.
    Wagner O; Schreier E; Heitz F; Maurer G
    Drug Metab Dispos; 1987; 15(3):377-83. PubMed ID: 2886315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.